Researchers from Washington State University and the University of Washington recently published results in the internationally, peer-reviewed journal Anticancer Research describing the addition of hyperbaric oxygen therapy to the anti-cancer (and anti-malarial) drug, artemisinin, dramatically increasing the drug’s effectiveness.
“In the new study, using artemisinin or high-pressure oxygen alone on a culture of human leukemia cells reduced the cancer cells’ growth by 15 percent. Using them in combination reduced the cells’ growth by 38 percent, a 50 percent increase in artemisinin’s effectiveness,” state the researchers. Encouraging comments also point toward the potential of using the combined treatment to battle breast cancer. To read more, click here.
